Makara Journal of Health Research
Volume 23
Issue 2 August

Article 8

8-1-2019

Protection against neutrophil extracellular trap (NET) toxicity by
antioxidant monoHER
Puji Astuti
Department of Pharmacology and Toxicology, Faculty of Health, Medicine, and Life Science, Maastricht
University, The Netherlands, pujiii.astutiii@gmail.com

Danielle M A Beurskens
Department of Biochemistry, Faculty of Health, Medicine, and Life Science, Maastricht University, The
Netherlands

Tanja Vajen
Department of Biochemistry, Faculty of Health, Medicine, and Life Science, Maastricht University, The
Netherlands

Gerry A F Nicolaes
Department of Biochemistry, Faculty of Health, Medicine, and Life Science, Maastricht University, The
Netherlands

Ming Zhang
Department of Pharmacology and Toxicology, Faculty of Health, Medicine, and Life Science, Maastricht
University, The Netherlands

See next page for additional authors
Follow this and additional works at: https://scholarhub.ui.ac.id/mjhr
Part of the Medicine and Health Sciences Commons

Recommended Citation
Astuti P, Beurskens DM, Vajen T, Nicolaes GA, Zhang M, Haenen GR, et al. Protection against neutrophil
extracellular trap (NET) toxicity by antioxidant monoHER. Makara J Health Res. 2019;23.

Protection against neutrophil extracellular trap (NET) toxicity by antioxidant
monoHER
Authors
Puji Astuti, Danielle M A Beurskens, Tanja Vajen, Gerry A F Nicolaes, Ming Zhang, and Guido R M M
Haenen

This article is available in Makara Journal of Health Research: https://scholarhub.ui.ac.id/mjhr/vol23/iss2/8

Makara J Health Res. 2019;23(2):108–115
doi: 10.7454/msk.v23i2.10453

Protection against neutrophil extracellular trap (NET) toxicity by antioxidant
monoHER
Puji Astuti1,2*, Danielle M A Beurskens3, Tanja Vajen4, Gerry A F Nicolaes3*, Ming Zhang1, Guido
R M M Haenen1
1. Department of Pharmacology and Toxicology, Faculty of Health, Medicine, and Life Science, Maastricht
University, 6229 ER Maastricht, The Netherlands
2. Polytechnic 'Aisyiyah Pontianak, Pontianak 78116, Indonesia
3. Department of Biochemistry, Faculty of Health, Medicine, and Life Science, Maastricht University, 6229 ER
Maastricht, The Netherlands
4. Department of Biochemistry, Faculty of Health, Medicine, and Life Science, Maastricht University, 6229 ER
Maastricht, The Netherlands
*

E-mail: pujiii.astutiii@gmail.com

Abstract
Background: Neutrophil extracellular traps (NET) are extracellular fibers produced by activated neutrophils to kill
bacteria. NET was recently found to be associated with several diseases, such as autoimmune diseases. NET formation,
called NETosis, is reactive oxygen species (ROS) dependent, thereby, prompting us to study its inhibition by potent
antioxidant monoHER as well as to study monoHER protection against NET toxicity caused by NET constituent histone
3 on endothelial cells. Methods: Freshly isolated neutrophils from male donors were stimulated with PMA to induce NET
formation. The effect of monoHER (50 µM) on oxidative burst (O2●− production) and NET formation was determined by
fluorescence microscopy. Flow cytometry was used to determine the protective effect of monoHER against NET toxicity
constituent histone 3 in EA.hy926 cells. Data was evaluated using ANOVA followed by the Bonferroni post-hoc test.
Results: MonoHER significantly reduced (p < 0.01) O2●− production of PMA-stimulated neutrophils and consequently
inhibited NET formation. MonoHER could also counteract histone 3 toxicity in EA.hy926 cells. Conclusions: MonoHER
might inhibit ROS-dependent NETosis pathway and also protect the endothelial cells against NET toxicity.
Keywords: antioxidants, extracellular matrix proteins, flavonoids, monoHER, neutrophils, protective agents

that they also play a role in various autoimmune
diseases.2–7 Due to their pivotal role in NETosis, ROS are
a potential theurapeutic target in NET-related diseases.
ROS,such as superoxide anion (O2●−) and hydroxyl
radical (●OH), contain unpaired electrons and therefore
easily oxidize molecules, such as DNA, proteins, and
lipids. Protection against ROS reactivity can be provided
by radical scavenging antioxidants that protect against
oxidative stress by donating electrons to ROS, which
takes away ROS reactivity.

Introduction
Neutrophil extracellular traps (NET) were first
discovered in 2004 as a novel defence strategy for
neutrophils against pathogens apart from their wellknown phagocytosis and degranulation strategies.1
During an infection, neutrophils are activated, resulting
in NET release into the extracellular space, where they
trap and kill pathogens. NETs are made up of
deoxyribonucleic acid (DNA) and chromatin that
assimilate with protein granules in the cytoplasm. These
granules comprise histones, neutrophil elastase (NE),
lysozyme, defensins, cathelicidins, and myeloperoxidase
(MPO), all of which contribute to NET toxicity for
pathogens and host cells.1,2 These NET protein–DNA
complexes trap microorganisms and consequently kill
them by membrane destruction. NETosis, a term used for
NET production by neutrophils, is irreversible, tightly
regulated, and requires presence of reactive oxygen
species (ROS). Although the original function of NET is
to combat microbial infection, recent studies have shown

MonoHER (7-mono-O-(β-hydroxyethyl)-rutoside)) is
the most powerful semi-synthetic antioxidant flavonoid
found in the drug Venoruton®.8 With O-(betahydroxythyl) rutosides as the main ingredient, venoruton
is widely used for venous insufficiency and edema.
MonoHER can provide direct protection against ROS as
well as can increase protection against ROS by increasing
the production of endogenous antioxidants by cells.9 Preclinical studies have shown that monoHER protects
against ROS driven dexorubicin cardiotoxicity.10
108
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Previously, it has been shown that antioxidants
comparable to monoHER, i.e., the flavonoids (−)epicathecin, (+)-catechin hydrate, and rutin trihydrate,
can inhibit PMA-induced ROS production of
inflammatory cells as well as ROS formation.11 Because
monoHER is reported to process extraordinary
antioxidant properties,8 we were prompted to investigate
the effect of monoHER on NETosis as well as its effect
to protect endothelial cells againts NET toxicity.

Methods
The medical ethical committee of Maastricht University
approved the collection of blood samples for this study.
All participants were healthy male donors (8 donors, 20–
32 years old) who did not have fever or inflammation as
well as did not consume alcohol and/or drugs at least 24
hours prior to blood collection. Each participant was
informed about the aim of the study and provided with a
written informed consent indicating his agreement to
participate. In this study, aside from monoHER, the
antioxidant (+)-catechin hydrate (Sigma-Aldrich,
Darmstadt, Germany) was used as a positive control 11 at
a concentration 50 µM. A stock solution of 36 mM NaOH
was prepared and then further diluted in 145 mM
potassium phosphate buffer pH 7.4 (ratio 1:3) to achieve
the desired concentration. Antioxidant solutions were
prepared daily, sterile filtered, and used within 3 hours
after preparation to prevent oxidation.
Neutrophil isolation from human blood. Around 24
mL of human peripheral blood was collected for
neutrophil
isolation
using
histopague-percoll
(Histopague 1119 & Percoll GE17, Sigma-Aldrich,
Darmstadt, Germany) density gradient centrifugation.12
The isolated neutrophils (>95% yield) were cultured in
complete RPMI 1640 medium supplemented with 25
mM HEPES (Lonza, Leusden, The Netherlands) and 1%
(v/v) fetal calf serum (FCS; Invitrogen, Breda, The
Netherlands) and used within 7 hours after isolation due
to their short life span.
Cell culture. The endothelial cell line EA.hy926
(ATCC® CRL-2922TM) was cultured in DMEM with 1%
L-glutamine supplemented with 10% (v/v) FCS, 1%
penicillin/streptomycin and enriched with 1× HAT
supplement 50× (All from Gibco, Beliswijk, The
Netherlands). The cells were cultured in a humidified
atmosphere of 37 oC, containing 5% CO2, and could be
used until passage 35.
Measurement of neutrophil oxidative burst.
Neutrophil O2●− production was determined according to
Chen et al 13 with minor modifications. Fifteen
microliters of human neutrophils (1.33 × 107/mL cell
suspension) were seeded into 96-well tissue culture plates
containing HBSS phenol red free and then pre-warmed in
the incubator at 37 oC and 5% CO2 for 1 h. For every
Makara J Health Res.

“sample” well with 5 µL of HBSS added, a “reference”
well was prepared by adding 5 µL of superoxide dismutase
(SOD). SOD was used as a “reference” to exclude any
－
signals beside O2● . Then, 80 µL of freshly made 100 µM
of cytochrome C containing 50 nM phorbol 12-myristate
13 acetate (PMA) (all from Sigma-Aldrich, Darmstadt,
Germany) with or without 50 µM flavonoid was added
into both sample and reference wells. PMA acted as a
stimulant to cause an oxidative burst in neutrophils.
Plates were incubated at 37 oC and 5% CO2, and after 2 h
the absorption at a wavelength of 550 nm was determined
using a microplate absorbance reader (Bio-Rad, The
Netherlands). The amount of O2●− was calculated using
the following formula:
∆𝑂𝐷550 = ∆𝑂𝐷550(𝑠𝑎𝑚𝑝𝑙𝑒) − ∆𝑂𝐷550(𝑆𝑂𝐷 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒)
∆𝑂𝐷550 × 47.4 = 𝑛𝑚𝑜𝑙 𝑂2●− /106 𝑐𝑒𝑙𝑙
Visualization of NET formation. Human neutrophils (2
× 105 cells/well of cell suspension) were seeded into 24
poly-L-lysine-coated well plates and incubated for 1 h at
37 oC. Prior to the treatment, neutrophils were preincubated with 50 µM antioxidant for 40 minutes or left
untreated for adaptation. Next, neutrophils were
stimulated with 1 µg/mL PMA either in combination
with 50 µM antioxidant or without antioxidant treatment
(control) over a period of 2 hours at 37 oC. After
incubation, neutrophils were fixated with 2%
paraformaldehyde (PFA) followed by a staining with 5
µM SytoxGreen (Sigma-Aldrich, Darmstadt, Germany).
NET formation was analyzed by fluorescence
microscopy using the EVOS FL Cell Imaging System
(Thermo Fisher, The Netherlands) with 20×
magnification.
Protection against histone 3 toxicity. EA.hy926 (105
cells/well of suspension) cells that have been cultured for
24 h were pre-incubated with 50 µM antioxidant for 10
minutes prior to treatment. 10 µg/mL of histone 3 (H3)
was incubated with either 50 µM of the antioxidant or 57
µg/mL heparin (positive control) or wasleft untreated and
incubated in an environment containing 5% CO2 at 37 oC
for 1 h. Consequently, the cells were washed with PBS,
harvested and spun down at 500 g for 5 minutes. The cell
pellets were resuspended in flow cytometry buffer
followed by staining with 2.5 µg/mL FITC–Annexin V
(Ax) and propidium iodide (PI) (all from Sigma Aldrich,
Darmstadt, Germany) before measurement with flow
cytometry (BD Accuri 6; BD Bioscience, The
Netherlands). In this experiment, live cells were negative
for both staining (Ax−, PI−), apoptotic cells were positive
for annexin V only (Ax+, PI−), and necrotic cells were
positive for PI only (Ax−, PI+) or Annexin V–PI positive
(Ax+, PI+)
Statistical analysis. Data were statistically analyzed by
using ANOVA with Bonferroni post-hoc test. The data
August 2019 | Vol. 23 | No. 1
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analysis included at least three replicates of independent
measurements (with two replicates), and an outlier
analysis was performed. The results were considered
statistically significant when p < 0.05. The figures of the
data were generated by GraphPad Prism 5.00 software
and significant differences were illustrated with asterisks.

Results
The antioxidant MonoHER inhibits PMA stimulated
ROS release of human neutrophils. PMA is a protein
kinase C (PKC) activator that activates the NADPH oxidase
complex to generate ROS, mainly superoxide (O2●−), which
is the key player in NETosis. In our experiment, the effect
of antioxidants on O2●− production was quantified by the
amount of electrons released from cytochrome C oxidation
(c2+ to c3+) as presented in Figure 1.
PMA proved to be a strong inducer of O2●− by generating
more than ten times the amount of O2●− as compared with
the PMA-untreated neutrophils (3.87 mmol/106 cells vs.
0.24 mmol/106 cells). In the treatment conditions, we
observed that 50 µM of monoHER strongly reduced the
amount of O2●− to 2.59 mmol/106 cells (p ≤ 0.01). The
effect of the positive control (+)-catechin was
comparable to the effect previously reported11 and was
also comparable to the effect of monoHER.
Visualization of MonoHER inhibition of NET
formation by fluorescence microscopy. Because
monoHER reduced O2●− production, it was expected that it
would also prevent NET formation. This effect of
monoHER on NETosis was investigated using fluorescence
microscopy. Human neutrophils were pre-incubated with
50 µM monoHER for 40 minutes prior to stimulation
with 1 µg/mL PMA. The NET release was visualized
using DNA staining with SYTOXgreen after PMA
incubation for 2 hours as shown in Figure 2. We observed
that PMA strongly induced NET formation and neutrophil
death (Figure 2c). The cells were flatter, larger, emitted
high intensity of fluorescence signal, and had extracellular
“threads” (indicated by the red arrow), indicating dead
cells due to NETosis. monoHER (50 µM) alone appeared
to be innocuous for neutrophils, which was deduced from
the low intensity of fluorescence (Figure 2b), similar to
unstimulated neutrophils (Figure 2a).
MonoHER (50 µM) appreared to reduce NET formation
of PMA-stimulated neutrophils (Figure 2d), indicated by
decreased “thread” formation as compared with the
PMA-stimulated neutrophil sample (Figure 2c).
Although these results indicate reduction of NET
formation by monoHER treatment, it was hard to
quantify its protective effect.
The protective effect of MonoHER against NET
component, histone 3. We also examined the impact of
monoHER on histone 3 protein toxicity, which is a
Makara J Health Res.
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constituent of NET that has been implicated in sepsis.14
The endothelial cell line EA.hy926 was cultured
overnight followed by incubation with 10 µg/mL histone
3, with or without 50 µM monoHER for 1 h at 37 oC.
Percentage of dead cells was assessed using Annexin V–
propidium iodide (PI) staining and quantified by flow
cytometry. As observed in Figure 3, incubation with 10
µg/mL of histone 3 (H3+) resulted in >50% cell death in
the EA.hy926 cell line. We found that most of the dead
cells were positive for PI and/or PI–annexin V, which
indicates that most dead cells were necrotic cells.
MonoHER (50 µM) reduced the number of necrotic cells
to as low as 33%. Heparin (57 µg/mL), served as positive
control, almost completely antagonized histone 3
toxicity.15 This result demonstrated the protective effect
of monoHER against histone 3 induced toxicity in
endothelial cells.

Discussion
The antioxidant MonoHER potentially inhibits
NETosis through ROS and NADPH-oxidase
prevention. Since their discovery, NETs have been
suggested to contribute to many non-infectious diseases,
such as diabetic, cancer, renal diseases, and autoimmune
diseases.16–19 Among the NET constituents, around 62%
have been identified as the target of autoantibodies in
systemic autoimmune diseases.2 Because neutrophils
make up approximately 60% of human’s white blood
cell,20 any compound that inhibits NET production might
be beneficial for NET-related disease treatment. Because
ROS are pivotal in NETosis, compounds that scavenge
ROS and/or impede their production may also inhibit
NET release, thereby forming a potential remedy for its
associated diseases. In this study, we hypo-thesized that
monoHER might inhibit NET formation by supressing
ROS production.
Prior to the discussion of the effect of monoHER on the
NET formation, it is important to understand the role of
ROS in NETosis. During neutrophil activation, PMA
binds to its PMA-receptor located on cell membranes,
resulting in NADPH-oxidase activation. NADPH-oxidase
is a membrane enzyme-complex that generates O2●−
radicals from oxygen oxidation.21 Superoxide radicals are
impermeable to the cell, but their oxidized product,
hydrogen peroxide (H2O2), can diffuse into the cells and
has a longer life span than superoxide. Hydrogen
peroxide (H2O2) can transform into hydroxyl radicals
(●OH), consequently increasing the concentration of total
oxidative radicals inside the cell, thereby leading to
oxidative stress.22 As a consequence, neutrophil elastase
(NE) translocates from the cytoplasm into the nucleus.
This elastase can initiate histone degradation, thereby
resulting in the relaxation and decondensation of the
chromatin, which is an early signal for the neutrophils to
undergo NETosis.23
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Antioxidants may inhibit NETosis through several
mechanisms (Figure 4). First, antioxidant can scavenge
extracellular superoxide; therefore, hydrogen peroxide
cannot be formed. Furthermore, antioxidant can also
enter the cells to scavenge intracellular ROS like
superoxide (O2●−) and the hydroxyl radical (●OH).
Second, certain antioxidants from the flavonoid family
can behave as an NADPH-oxidase inhibitor and can
hence diminish superoxide production.24 These multifunctional properties of antioxidants are thought to
protect ROS toxicity and consequently avert NETosis. In
the present study, MonoHER significantly reduced the
amount of superoxide (O2●−) in PMA stimulated
neutrophils. In addition, monoHER quickly scavenged
and neutralized superoxide due to its site-specificscavenging activity.8 MonoHER proved to diminish
superoxide (O2●−) production, thereby indicating that it
can also inhibit NETosis. Although other antioxidants,
such as (−)-epicatechin, (+) catechin hydrate, and rutin
trihydrate, also inhibit NETosis by ROS neutralization,10
our preliminary data showed that quercetin (another type
of antioxidant) did not supress superoxide (O2●−)
production. This finding indicates that only specific
antioxidants can work as a NET-related disease remedy.
In our study, the antioxidant monoHER also inhibited
PMA-stimulated NET release from human neutrophils,
indicated by less NET formation as detected by
fluorescence microscopy.
Although our results are promising, they need to be
confirmed, preferably using a more accurate quantitative
analysis. Because NET is quite a new topic of research,
there is no generally established quantification method.
The use of a single marker on NET quantification, such
as DNA staining with SYTOXgreen, may not be
adequate (based on our preliminary data) and therefore
needs to be validated with other markers. For example,
DNA staining can be combined with other markers for
NET proteins, such as antibodies for histones, MPO,
catalase, or cathepsin G in flow cytometric analysis. The
use of several types of markers to detect NET release in
neutrophils may increase the sensitivity of the assay and
may also give a better read out for NET quantification
analysis.
The protection of monoher against NET component,
histone 3 toxicity. Protein histones are abundantly
present in NET and are highly toxic. Although the exact
mechanisms of histone toxicity remain elusive, we
assume that it involves their high positive charge, which
is a weapon for them to kill bacteria by making pores in
the bacterial cell membrane.25 The same strong positive
charge of the histones (pl ~10.5) can also create pores in
negatively charged endothelial cell membranes (pl ~4.5),
which is detrimental for the cells.26 It has been shown that
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extracellular histones from NET are toxic and promote
vascular necrosis in severe glomerulonephritis (GN).27
Histones are reported to enhance the production of proinflammatory cytokine tumor necrosis factor-alfa (TNFα), resulting in an oxidative stress condition.28,29 Both
high expression of TNF-α and oxidative stress activate
caspase-dependent cell death. 29
In our study, the toxic effect of histone 3 was
counteracted by antioxidant monoHER. This might also
involve the ability of monoHER to efficiently scavenge
ROS, thereby stopping oxidative stress signalinginduced cell death as showed in Figure 5. During the
scavenging of ROS, monoHER is oxidized to monoHER
quinone, which is a relatively “soft” electrophile that
according to the Pearson’s hard-soft-acid base concept
preferably reacts with soft electrophiles.30 The thiol
group on Kelch-like ECH-associated protein 1 (KEAP1),
one of the redox sensors in the cell, appears to be one of
the groups that quickly reacts with monoHER quinone,
thereby resulting in the dissociation of nuclear factor
erythroid 2-related factor (Nrf2) from its complex with
KEAP1.31
Consequently, the freed Nrf2 translocates to the nucleus
where it binds to antioxidant response elements (AREs)
on DNA to enhance the synthesis of antioxidants to
induce better cellular adaptation against oxidative stress.
However, additional experiments are needed to
determine the effect of this adaptation on the protection
provided by monoHER. Autoimmune disease is one of
causes of death in American woman with no effective
treatment. Treatment of autoimmune diseases has relied
on immunosuppressive medications, which attract the
immune system in general. Because antioxidant
monoHER showed a protection effect on NETosis and
it’s constituent, monoHER might be an alternative
therapeutic strategies for autoimmune diseases, without
hindering the general immune system.

Conclusions
In our study, we proved that monoHER, can efficiently
scavenge superoxide (O2●−) and can inhibit O2●−
production, a key player in NETosis. Although we could
not provide quantitative evidence, our semi-quantitative
microscopy analysis showed promising inhibitory effects
of monoHER on NET release. Moreover, monoHER also
counteracted the toxic effect of NET constituent, histone
3 as exhibited in our study. With these results, monoHER
might provide a new therapy for patients with
autoimmune diseases. With regard to autoimmune
diseases, an investigation on cellular adaptation provided
by monoHER should be conducted.
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Figure 1. The effect of monoHER (MH) on PMA-stimulated superoxide radical (O2●−) production by human neutrophils. Catechin
hydrate/Cat was used as a positive control. Values are expressed as mean (n = 3) and standard deviation. *p ≤ 0.05, **p ≤ 0.01, ns: not
significant.

PMA (−)

PMA (+)

(−)

50 μM MonoHER

(−)

(a)

(b)

(c)

50 μM MonoHER

(d)

Figure 2. The effect of monoHER on NET formation in neutrophils. NET formation was induced by PMA and was visualized by
fluorescence microscopy (panel c and d). Unstimulated neutrophils (PMA−) (panel a) display less fluorescence as compared with the
PMA-stimulated neutrophils (PMA+) (panel c). MonoHER had no effect on unstimulated neutrophils (panel b), but monoHER
appeared to reduce PMA-stimulated NET formation in neutrophils (panel d). The red arrow points toward a NET.
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Figure 3. monoHER protection against histone 3 toxicity in the endothelial cell EA.hy926. Endothelial cells were incubated with 10
μg/mL of histone 3 (H3+) and 50 µM monoHER or 57 µg/mL heparin (positive control) for 1 h. The percentage of viable, apoptotic,
and necrotic cells were expressed as percentage (%) of the total number of cells.

Figure 4. Antioxidant (AOX) protection against ROS. Antioxidant can prevent ROS formation by inhibiting NADPH-oxidase.
Antioxidant can also scavenge extracellular (ex) and intracellular (in) ROS, such as superoxide (O2●−) and hydroxyl (OH●) radicals.
The inhibition of ROS formation and scavenging of ROS by antioxidant can prevent ROS-dependent suicidal NETosis.
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Figure 5. The adaptive response of monoHER toward histone toxicity. (A) ROS cause toxicity by damaging DNA, proteins and lipids.
They also induce an adaptive response via the Nrf2 pathway. Due to the oxidative damage to KEAP1, Nrf2 dissociates form its complex
with KEAP1. After translocation to the nucleus, the freed Nrf2 binds to the antioxidant responsive elements on the DNA and induces
adaptation (B) When monoHER is present, it will scavenge ROS thereby preventing cellular adaptation. Moreover, monoHER is
converted into the soft electrophile monoHER quinone that quickly reacts with the soft thiol group on KEAP1, leading to the
dissociation of Nrf2 and the subsequent adaptation as described for panel A. Adaptive response in the presence of monoHER appeared
to be higher than the adaptive response without monoHER. This might be an advantage of monoHER over other antioxidants.
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